The Impact of Foramen Magnum Decompression With versus Without Duraplasty on Symptom Improvement and Syrinx Reduction in Chiari 1 Malformation Patients

枕骨大孔减压术联合或不联合硬脑膜成形术对Chiari I型畸形患者症状改善和脊髓空洞缩小的影响

阅读:1

Abstract

INTRODUCTION: Surgical decompression is considered the gold standard of treatment for patients with Chiari 1 malformation who are symptomatic or with syrinx. Currently, foramen magnum decompression with duraplasty (FMDD) and without duraplasty (FMD) are the two most commonly used techniques. This retrospective analysis aims to compare clinical improvement and syrinx reduction in patients undergoing FMDD versus FMD. MATERIALS AND METHODS: Clinical and radiological assessments were conducted pre- and postoperatively. Patient data was collected from electronic records and analyzed using univariate and multivariate regression analysis in R. RESULTS: Fifty-eight patients underwent FMDD and 38 patients underwent FMD. No difference in likelihood for symptom improvement (adjusted odds ratio [aOR] 0.96, p  = 0.95) or syrinx reduction (aOR 1.69, p  = 0.62) was seen between FMD and FMDD. Headaches were associated with increased likelihood for symptom improvement (aOR 4.83, p  = 0.03), while unsteadiness (aOR 0.18, p = 0.03) and neck pain had lower likelihood for overall symptom improvement (aOR 0.23, p  = 0.03). The presence of limb symptoms (aOR 16.45, p  = 0.03) was associated with a higher likelihood while older age (aOR 0.95, p  = 0.03) and male sex (aOR 0.04, p  = 0.02) had lower likelihood for syrinx reduction. FMD was associated with a shorter length of stay (mean difference 1.94, p  = 0.00). CONCLUSION: No differences in overall symptom improvement or syrinx reduction were seen between patients undergoing FMD and FMDD. However, patients undergoing FMDD had longer lengths of stay in hospital. The lack of difference in symptom improvement and syrinx reduction may promote FMD as a better surgical technique. Furthermore, the role for individual symptoms in predicting symptom improvement and syrinx reduction was demonstrated. Larger studies will be required to validate which technique is better suited for patients with Chiari 1 malformations and to investigate the role of symptoms in predicting outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。